Pfizer Postpones FDA Request On Vax For Kids Under 5

NBC News reports:

Pfizer-BioNTech is postponing its rolling application to the Food and Drug Administration to expand the use of its two-dose Covid-19 vaccine for children ages 6 months to 4 years.

The move means that vaccines for this age group will not be available in the coming weeks, a setback for parents eager to vaccinate their young children.

Pfizer said on Friday that it will wait for its data on a three-dose series of the vaccine, because it believes three doses “may provide a higher level of protection in this age group.” Data on the third dose is expected in early April, the company said.

Read the full article.

Pfizer postpones FDA request for COVID vaccine for kids under 5https://t.co/nsukbL8Wj9

— Ryan Smith (@RyanReports) February 11, 2022